Heart Rhythm Disorders Clinical Trial
Official title:
Panorama 2 Medtronic CRDM Implantable Cardiac Device Long Term Registry
Understanding the clinical practice of treatment of cardiac rhythm disorders all over the
world and understanding the clinical outcomes of the treatment with its cardiac rhythm
products in real world patient population is essential for Medtronic to be able to
effectively develop new products and adjust existing products. In addition Medtronic is
committed to monitor the safety of its products throughout the entire life cycle to ensure
maximum product reliability.
The Panorama 2 registry will enable Medtronic to increase data collection of clinical
practice with Medtronic implantable Cardiac Rhythm and Disease Management (CRDM) devices in
various regions across the world and on product reliability of its CRDM devices.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03945968 -
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
|
||
| Completed |
NCT03835169 -
Intra Hospital Mortality Risk Factors in Patients Admitted to Cardiac Intensive Care Units in 2017 in France
|
||
| Recruiting |
NCT01888315 -
Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity
|
Phase 1/Phase 2 |